This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Baicalin prevents myocardial ischemia/reperfusion injury through inhibiting ACSL4 mediated ferroptosis
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFerroptosis and cancer prognosis · Trace Elements in Health · Redox biology and oxidative stress
The journal retracts the 14th of April 2021 article cited above.
Following publication, concerns were raised regarding the integrity of the data in the published Figure 1C, and the subsequent duplication 3 years later of this image (Figure1A) in another journal’s published article (Kardiologiia, 2024 October 31; 64 (10):48–56. doi: 10.18087/cardio.2024.10.n2739). The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.
This retraction was approved by Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. The authors have not responded to correspondence regarding this retraction.